Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Conmed ( (CNMD) ).
On December 5, 2025, CONMED Corporation announced its strategic decision to exit its gastroenterology product lines as part of its portfolio optimization strategy. This move includes terminating its distribution agreement with W.L. Gore & Associates for the Gore® VIABIL® biliary stent, effective January 1, 2026, and exiting other gastroenterology products. The company aims to focus on its core markets, such as minimally invasive surgery and orthopedic soft tissue repair, to enhance long-term success and leadership in surgical innovation. Financially, the exit is expected to improve CONMED’s gross margin profile by approximately 80 basis points, despite an anticipated EPS dilution of $0.45–$0.55 in 2026. The company reaffirms its 2025 revenue and EPS guidance, indicating no material impact on its financial results for that year.
The most recent analyst rating on (CNMD) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Conmed stock, see the CNMD Stock Forecast page.
Spark’s Take on CNMD Stock
According to Spark, TipRanks’ AI Analyst, CNMD is a Neutral.
Conmed’s overall stock score reflects strong financial performance and strategic initiatives for growth, tempered by technical weakness and challenges in profitability. The shift in capital allocation strategy and recent earnings call insights contribute positively, but technical indicators suggest caution.
To see Spark’s full report on CNMD stock, click here.
More about Conmed
CONMED Corporation is a medical technology company that provides devices and equipment for surgical procedures. The company’s products are utilized by surgeons and healthcare professionals across various specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.
Average Trading Volume: 436,370
Technical Sentiment Signal: Sell
Current Market Cap: $1.37B
See more insights into CNMD stock on TipRanks’ Stock Analysis page.